INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

77,304 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
20.0K sh
Apr 20, 2026Apr 20, 2026
Page 1111 of 1933
← PrevNext →
traded Apr 20, 2026
+0d
SEC Form 4

Evidence

12
WO
White Timothy OgdenPresident
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
454.6K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$66K
860 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

12
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
37.1K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
266.3K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$101K
1,317 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

12
WO
White Timothy OgdenPresident
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
8,726 sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$56K
734 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

12
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$111K
1,448 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

12
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$176K
2,298 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

12
CS
Chen ShipingDirector, Chief Operating Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
300.9K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$110K
1,444 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

12
WT
West TonySee Remarks
UBERUber Technologies, Inc
Tax withholding
F$57K
749 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

12
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
24.0K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
WO
White Timothy OgdenPresident
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
8,532 sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
EL
Etzkorn LillianEVP, CFO
LCIILCI INDUSTRIES
Option exercise
M$140K
1,131 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

12
CS
Chen ShipingDirector, Chief Operating Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
300.9K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
266.3K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
42.3K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
1.03M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
LJ
Langhans JarrodChief Financial Officer
CELHCelsius Holdings, Inc.
Tax withholding
F$155K
4,391 sh
Apr 18, 2026Apr 20, 2026
traded Apr 18, 2026
+2dSEC Form 4

Evidence

12
WO
White Timothy OgdenPresident
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
29.4K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
CR
Chambers RebeccaDirector
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
140.6K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
5.51M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$54K
710 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

12
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Tax withholding
F$57K
748 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

12
MJ
McAnear Justin J.Chief Financial Officer
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
570.7K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Other acquisition or disposition
J—
5.51M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

12
WL
Wong Jennifer L.Chief Operating Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$3.73M
23.0K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

11
AL
Azar Samak LChief Legal Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$24K
500 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

10
SS
Subramanian SrinivasExecutive Vice President
NDSNNORDSON CORP
Option exercise · 10b5-1 plan
M$205K
1,900 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

10
LH
Litinsky James H.Director, Chairman and CEO
MPMP Materials Corp. / DE
Open-market sale · 10b5-1 plan
SELL$16.60M
259.2K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
CS
Chen ShipingDirector, Chief Operating Officer
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
176.2K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
LB
Larson Robert BruceSVP & Chief Accounting Officer
ACIAlbertsons Companies, Inc.
Grant or award
A—
7,636 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
2,547 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M—
1,125 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

9
KA
Krishnamurthy Balaji (A)Chief Financial Officer
UBERUber Technologies, Inc
Option exercise
M—
1,158 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
1.02M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,888 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Tax withholding
F$40K
528 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence